Intermolecular Inc (IMI)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2008 | |
| Cash Flows From Operating Activities | |
| Net Income | -9,500 |
| Depreciation Amortization | 3,430 |
| Accounts receivable | -831 |
| Accounts payable and accrued liabilities | 960 |
| Other Working Capital | 6,055 |
| Other Operating Activity | 867 |
| Operating Cash Flow | $981 |
| Cash Flows From Investing Activities | |
| PPE Investments | -7,631 |
| Purchase Sale Intangibles | -531 |
| Other Investing Activity | -531 |
| Investing Cash Flow | $-8,162 |
| Cash Flows From Financing Activities | |
| Debt Issued | 3,000 |
| Debt Repayment | -1,749 |
| Common Stock Issued | 178 |
| Other Financing Activity | 19,910 |
| Financing Cash Flow | $21,339 |
| Beginning Cash Position | 26,744 |
| End Cash Position | 40,902 |
| Net Cash Flow | $14,158 |
| Free Cash Flow | |
| Operating Cash Flow | 981 |
| Capital Expenditure | -7,631 |
| Free Cash Flow | -6,650 |